ArshamSheybaniMD
Ophthalmology • Saint Louis, MOAnterior Segment Related, Cataract Related, Glaucoma Related
Associate Professor, Ophthalmology & Visual Sciences, Washington University in St. Louis School of Medicine Residency Program Director; Fellowship Director, Glaucoma and Anterior Segment Surgery
Dr. Sheybani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4901 Forest Park Ave
Fl 6
Saint Louis, MO 63108Phone+1 314-362-3937Fax+1 314-362-3725
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2009 - 2012
Mercy Hospital (St Louis)Internship, Transitional Year, 2008 - 2009- Washington University in St. Louis School of MedicineClass of 2008
Certifications & Licensure
MO State Medical License 2012 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 34 citationsOpen-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP VariationArsham Sheybani, Rachel A. Scott, Thomas W. Samuelson, Malik Y. Kahook, Daniel I. Bettis
Ophthalmology and Therapy. 2020-03-01 - 143 citationsFluid Dynamics of a Novel Micro-Fistula Implant for the Surgical Treatment of GlaucomaArsham Sheybani, Herbert A. Reitsamer, Iqbal Ike K. Ahmed
Investigative Ophthalmology & Visual Science. 2015-07-01 - 14 citationsSingle Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension.Felipe A Medeiros, Arsham Sheybani, Manjool M Shah, Marcos Rivas, Zhanying Bai
Ophthalmology and Therapy. 2022-08-01
Authored Content
- Nearly 20% of Glaucoma Surgeries for POAG Fail After 5 YearsFebruary 2022
Press Mentions
Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma PatientsSeptember 17th, 2024
Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP VariationNovember 15th, 2019
Optic Truncation for Negative DysphotopsiaJuly 2nd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
